ForteBio cordially invites you to attend our second Octet User Group Meeting, directly following the IBC BioProcessing International Conference in Boston, MA. USA.

Who should attend?

• Scientists in lead optimization and development of antibody and protein therapeutics in pharma, biotech and CRO companies
• Scientists using label-free technologies for measuring kinetics or real-time binding
• Scientists in bioprocessing requiring label-free, real-time precision methodology for measuring bioreactor titers.

Octet User Presentations:

• Use of ForteBio Octet for Quantitative Titer Analysis in Biopharmaceutical Development
  Mark Hardy, Ph.D. — Senior Scientist, BCA
  Wyeth Biopharmaceuticals
• Integration of a New Technology into Pfizer’s Reagent Antibody Facility —A New Tool for the Analytical Kid in All of Us
  Joseph Gardner, Ph.D. — Research Scientist, Reagent Antibody Center of Emphasis
  Pfizer Global Research and Discovery
• Protein-Carbohydrate Binding Interactions
  Dan Roseman, Ph.D. — Senior Scientist, Pharmaceutical and Analytical Development
  Shire Pharmaceuticals
• Characterization of Biotherapeutics at AVEO Pharamaceuticals
  Lyne Breault, Scientist I
  Aveo Phramaceuticals
• Using Octet for Rapid Development of Homogeneous Immunoassays
  Vitor Shifrin, Ph.D. — President
  Drug Discovery Solutions

To register for this free event, please RSVP to this email. We look forward to your participation. For more information, please contact jconcepcion@fortebio.com.